ExpressionMR400InstructionsforUse SpecificationsA‐13
*Forkilopascals(kPa),allow±1leastsignificantdigittoaccommodateround‐offerrorforcalculatedvalues.
A.
(FromISO80601‐2‐55.FDArecommendedforahealthy40‐yearoldmale.)
B.
Alarm Limits
End‐tidalCO2
Lower
Upper
Off,or5to60mmHg(Off,or0.7to8.0kPa)
5to90mmHg,oroff(0.7to12.0kPa,oroff)
FractionalinspiredCO2
Lower
Upper
Nolowalarm;
0to20mmHg,oroff(0to2.7kPa,oroff)
Respiration
Lower
Upper
Off,or4to40
RPM
20to100RPM,oroff
GAS or Vapor Halothane
Enflurane Isoflurane Desflurane Sevoflurane N
2
O
MAC Level, % vol fraction 0.77 1.70 1.15 6.00 2.10 105
Measured
Quantitative Effects of Gas or Vapor
Gas
N
2
O HAL ENF ISO SEVO Xenon Helium DES Ethanol Isopropanol Acetone Methane
Carbon
Dioxide
NE @
60%
NE
@
4%
NE
@
5%
NE
@ 5%
NE
@
5%
ME1
@
80%
NE @
50%
ME2
@
15%
NE @
0.1%
NE @
0.1%
NE @
0.1%
NE @
1%
No Effect (NE)
Minimal Effect 1 (ME1) = Negatively bias Carbon Dioxide values by up to an additional 5 mmHg at 38 mmHg
Minimal Effect 2 (ME2) = Concentrations greater than 5% will positively bias Carbon Dioxide values by up to an additional 3 mmHg at 38
mmHg
***Metered dose inhaler propellants: Unspecified
Invasive Blood Pressure (Optional)
Pressure Amplifier
IsolationVoltage 5KVDC
SignalRange ‐30to+250mmHg
Sensitivity 5µV/V/mmHg
GainAccuracy ±0.5percent
Bandwidth 0to10Hz(‐3dB)
CO2 (Optional LoFlo)